跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOFILEX CAPSULE 250 mg - HSA Drug Approval Details
Approvals
/
HSA
/
SOFILEX CAPSULE 250 mg
Approved
THERAPEUTIC
SOFILEX CAPSULE 250 mg
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
🇸🇬 Health Sciences Authority
Approval Date
Nov 4, 1998
Approval ID
db1febd0c2e0a2f7
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Type
Therapeutic
Approval Details
Approval Id
db1febd0c2e0a2f7
Drug Name
SOFILEX CAPSULE 250 mg
Product Name
SOFILEX CAPSULE 250 mg
Approval Number
SIN10378P
Approval Date
1998-11-04
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
J01DB01
Atc Item Name
cefalexin
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Company Detail Path
/organization/apex-pharma-marketing-pte-ltd
Active Ingredients
CEPHALEXIN MONOHYDRATE EQV CEPHALEXIN
250 mg
CEPHALEXIN MONOHYDRATE EQV CEPHALEXIN
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 4, 1998
Approval ID
db1febd0c2e0a2f7
Type
Therapeutic
Back to HSA Approvals